A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Tolley K, Hutchinson M, You X, Wang P, Sperling B, Taneja A, Siddiqui M K, Kinter E
PLoS One. 2015; 10(6):e0127960. Epub 2015 Jun 03. PMID: 26039748.Abstract